Amgen – Working With External Innovators
California Lutheran University, Swenson 101
141 Faculty Drive, Thousand Oaks, CA
Amgen’s growth is fueled by more than the results of the research taking place in its laboratories. Today, roughly 50 percent of Amgen’s portfolio is comprised of innovations that have come from outside of the company. Amgen’s Business Development team works with potential partners on out-licensing and in-licensing, mergers and acquisitions, corporate venture capital investments; deal integration efforts, and post-deal alliance management activities. With ever-evolving macro-economic conditions, advances in technologies, government policies, and physician behavior, business development strives to have a pulse check on real-world issues and their impact on Amgen’s overall strategy.
Dr. Syed Kazmi, Executive Director of Transactions, will explain the range and depth of expertise brought together to explore external opportunities, the thoroughness of the evaluations, the strategic thinking placed in aligning and positioning future partners, and the process to integrate new solutions into the Amgen business. He will also talk about how outside parties and Amgen interact and Amgen’s focus on acquiring the best talent.
For more information visit: http://www.eventbrite.com/e/amgen-working-with-external-innovators-tickets-26793214225?aff=erelexpmlt